Cassava Sciences Announces Conference Call for Second Quarter Financial Results
The conference call is scheduled to begin at
|Conference call detail are as follows:
After the live call, the event will be archived on the ‘Investors’ page of the Company’s website: https://www.CassavaSciences.com.
Live Event Click to Join Link (for participant entry):
About Alzheimer’s Disease
Alzheimer’s disease is a progressive brain disorder that destroys memory and thinking skills. As of 2020, there were approximately 50 million people worldwide living with dementia, a figure expected to increase to 150 million by 2050.1 The annual global cost of dementia is now above
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years,
For More Information Contact:
For information regarding risks related to our business, investors please consult our filings with the
Source: Cassava Sciences, Inc.